A citation-based method for searching scientific literature

M Moschetta, A George, S B Kaye, S Banerjee. Ann Oncol 2016
Times Cited: 94



Clare L Scott, Elizabeth M Swisher, Scott H Kaufmann. J Clin Oncol 2015
Times Cited: 235




List of shared articles



Times cited

Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy.
Graziela Z Dal Molin, Kohei Omatsu, Anil K Sood, Robert L Coleman. Ther Adv Med Oncol 2018
13

Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
Chee Khoon Lee, Michael L Friedlander, Angelina Tjokrowidjaja, Jonathan A Ledermann, Robert L Coleman, Mansoor R Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Ralph Bloomfield, Sandra Goble,[...]. Cancer 2021
1

[Abnormalities of DNA repair and gynecological cancers].
AurĂ©lie Auguste, Alexandra Leary. Bull Cancer 2017
3


DNA damage response as a therapeutic target in gynecological cancers.
Alexandra Leary, Aurelie Auguste, Soizick Mesnage. Curr Opin Oncol 2016
6

Rucaparib in ovarian cancer: extending the use of PARP inhibitors in the recurrent disease.
Graziela Z Dal Molin, Shannon N Westin, Robert L Coleman. Future Oncol 2018
4

Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment.
Belinda van Zyl, Denise Tang, Nikola A Bowden. Endocr Relat Cancer 2018
46